Blue Gold Faces Third Nasdaq Deficiency as MVPHS Drops Below $15M
BGL is trading near its 52-week low of $0.19 (10% above the low) on light trading volume (0.1× avg).
Summary
Blue Gold received a third Nasdaq deficiency notice—this time for MVPHS below $15 million—compounding its existing bid-price and market-value listing problems. The company plans to seek a transfer to the Nasdaq Capital Market.
Key Events · Legal and Risk Events · BGL
-
Third Nasdaq Deficiency Received
On July 24, 2026, Nasdaq notified Blue Gold that its MVPHS had fallen below the $15 million minimum for 30 consecutive business days, adding to prior bid-price and market-value deficiencies.
-
Compliance Deadline Set
The company has 180 calendar days, until January 20, 2027, to regain MVPHS compliance by maintaining a $15 million MVPHS for at least 10 consecutive business days.
-
Transfer to Nasdaq Capital Market Planned
As part of its compliance strategy, Blue Gold intends to apply to transfer its listing to the Nasdaq Capital Market, which has lower continued listing requirements.
-
No Immediate Delisting
The deficiency notice does not immediately affect trading; BGL shares continue to trade on the Nasdaq Global Market while the company works to regain compliance.
Analysis · BGL · Energy & Transportation
A fresh Nasdaq deficiency notice has landed on Blue Gold, this time because its market value of publicly held shares (MVPHS) slipped below the $15 million threshold. The notice adds to the two deficiencies disclosed on July 8—the $1.00 bid price and $50 million market value—leaving the company grappling with three simultaneous listing challenges. To regain MVPHS compliance, it has until January 20, 2027, and intends to apply for a transfer to the Nasdaq Capital Market, where the requirements are less stringent. This third strike deepens the delisting risk and underscores the company's fragile market position.
At the time of this filing, BGL was trading at $0.21 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $8.1M. The 52-week trading range was $0.19 to $18.21. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.